SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001213900-19-011604
Filing Date
2019-06-27
Accepted
2019-06-27 15:10:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g0619hbl_enlivexthera.htm SC 13G 54672
  Complete submission text file 0001213900-19-011604.txt   56359
Mailing Address P.O.B. 12000 JERUSALEM L3 91120
Business Address P.O.B. 12000 JERUSALEM L3 91120 972-2-677-9424
HBL- HADASIT BIO-HOLDINGS LTD. (Filed by) CIK: 0001520433 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
Enlivex Therapeutics Ltd. (Subject) CIK: 0001596812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88278 | Film No.: 19925045
SIC: 2834 Pharmaceutical Preparations